Milestone Scientific Inc

Milestone Scientific Inc(MLSS)股票分析

$0.502

-0.003 (-0.59%)收盤時

Loading chart…
High
0.512
Open
0.494
VWAP
0.50
Vol
29.49K
Mkt Cap
52.51M
Low
0.493
Amount
14.81K
EV/EBITDA, TTM
-10.42

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

AI analysis of Milestone Scientific Inc (MLSS)

hold

Milestone Scientific Inc is not a strong buy right now due to mixed signals in financial performance and insider selling. The current price is $0.502, with a recent 5-day change of +4.41%, but the stock has a concerning insider selling increase of 2723.48%.

Analyst Ratings (1)

+99.20% upside
Buy
1 Buy
0 Hold
0 Sell
Current: 0.50
最低
1.00
平均
1.00
最高
1.00

Benchmark

2025-11-20

目標價

$1

Speculative Buy

Benchmark

2024-11-20

目標價

$1.25

Buy

Benchmark

2024-10-10

目標價

$1.25

Buy

估值指標

The current forward P/E ratio for Milestone Scientific Inc (MLSS) is 18.21, compared to its 5-year average forward P/E of -10.12.

Forward P/E

Strongly Overvalued
5Y Average P/E
-10.12
Current P/E
18.21
高估
2.44
低估
-22.68

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
-0.83
Current EV/EBITDA
-10.42
高估
1.42
低估
-3.08

Forward P/S

Fair
5Y Average P/S
6.02
Current P/S
3.95
高估
8.97
低估
3.08

Alphio AI Price Scenarios for MLSS

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MLSS

$0.99

情境價格

B

Base

Base · 50%MLSS

$0.88

情境價格

B

Bear

Bear · 25%MLSS

$0.85

情境價格

事件時間軸

2026-07-01 (ET)

12:00:00

Markets Mixed as Semiconductor Stocks Slip

09:30:00

Company Reports 300% Revenue Growth in Q2

2026-05-14 (ET)

16:30:00

Dow Rises 370 Points as Markets Optimistic on US-China Talks

12:10:00

Dow Rises on Cisco Earnings, Market Optimism

07:40:00

Milestone Scientific Q1 Revenue $2.16M, Below Consensus

資訊

MLSS FAQ — answered by Alphio AI

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Milestone Scientific Inc is not a strong buy right now due to mixed signals in financial performance and insider selling. The current price is $0.502, with a recent 5-day change of +4.41%, but the stock has a concerning insider selling increase of 2723.48%.

1 analysts cover MLSS: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 1.00.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始